Clinical Bottom Line:
|
The Evidence: [1,2] Two large unblinded RCTs.
| Study (n) with outcome | Medical Tx | CABG | RRR | ARR (95% CI) | NNT |
| [1] VACS (n = 686); All patients; 11 yr mortality 3 vessel with ¯ LVEF; 11 yr mort. 2/3 clin. risk. factors; 11 yr mort. Left main stenosis > 50%; 2 yr mort. |
- .43 .62 .64 .32 |
- .42 .50 .51 .15 |
- .02 .19 .20 .53 |
- .01 (-.04 to .06) .12 ( .07 to .17) .13 ( .07 to .18) .17 ( .13 to .22 |
- NS 8 8 6 |
|---|---|---|---|---|---|
| [2] CASS (n = 780); All patients; 10 year mortality Angina (5 year assessment) 23 vessel with ¯ LVEF; 7 yr mortality |
- .21 .44 .43 |
- .18 .30 .25 |
- .14 .29 .32 |
- .02 ( -.01 to .05) .14 ( .09 to .19) .18 ( .13 to .22) |
- NS 7 6 |
Comments:
References:
Click here to comment on this CAT |
![]() |
Click here to comment on this CAT |
![]() |